Eli Lilly & Co (LLY) just unveiled an announcement.
Dr. Marschall S. Runge is set to retire from the Board of Directors of Eli Lilly and Company by the end of August 2024. His departure is amicable, with no disagreements over the company’s operations, policies, or practices influencing his decision. Eli Lilly announced his retirement publicly, underscoring a smooth transition in their corporate governance.
For a thorough assessment of LLY stock, go to TipRanks’ Stock Analysis page.